Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rapid determination of doxorubicin and its fluorescent metabolites by high pressure liquid chromatography.

× No keyword cloud information.

14 in total

1. Metabolism of daunorubicin in sensitive and resistant Ehrlich ascites tumor cells. Determination by high pressure liquid chromatography.

Authors: D Londos-Gagliardi; R Baurain; J Robert; G Aubel-Sadron
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

2. Accumulation and metabolism of new anthracycline derivatives in the heart after IV injection into mice.

Authors: D Deprez-de Campeneere; R Baurain; A Trouet
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

3. Evaluation of anthracycline cardiotoxicity with the model of isolated, perfused rat heart: comparison of new analogues versus doxorubicin.

Authors: P Pouna; S Bonoron-Adèle; G Gouverneur; L Tariosse; P Besse; J Robert
Journal: Cancer Chemother Pharmacol Date: 1995 Impact factor: 3.333

4. Improved high-performance liquid chromatography assay of doxorubicin: detection of circulating aglycones in human plasma and comparison with thin-layer chromatography.

Authors: D E Brenner; S Galloway; J Cooper; R Noone; K R Hande
Journal: Cancer Chemother Pharmacol Date: 1985 Impact factor: 3.333

Review 5. Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.

Authors: J Bouma; J H Beijnen; A Bult; W J Underberg
Journal: Pharm Weekbl Sci Date: 1986-04-25

6. Uptake, metabolism, and cytotoxicity of doxorubicin in human Ewing's sarcoma and rhabdomyosarcoma cells.

Authors: M W DeGregorio; G M Lui; B A Macher; J R Wilbur
Journal: Cancer Chemother Pharmacol Date: 1984 Impact factor: 3.333

7. Plasma levels of doxorubicin after IV bolus injection and infusion of the doxorubicin-DNA complex in rabbits and man. Comparison with free doxorubicin.

Authors: R Baurain; D Deprez-De Campeneere; A Zenebergh; A Trouet
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

8. Doxorubicin and 5-fluorouracil plasma concentrations and detectability in parotid saliva.

Authors: L A Celio; G J DiGregorio; E Ruch; J Pace; A J Piraino
Journal: Eur J Clin Pharmacol Date: 1983 Impact factor: 2.953

9. Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles.

Authors: J Kattan; J P Droz; P Couvreur; J P Marino; A Boutan-Laroze; P Rougier; P Brault; H Vranckx; J M Grognet; X Morge
Journal: Invest New Drugs Date: 1992-08 Impact factor: 3.850

10. Uptake and metabolism of daunorubicin by human leukemia cells.

Authors: M W DeGregorio; C J Carrera; J C Klock; J R Wilbur
Journal: Cancer Chemother Pharmacol Date: 1982-12 Impact factor: 3.333